Levoleucovorin Calcium
Who holds supplier records for Levoleucovorin Calcium? 5 organisations hold a current record for Levoleucovorin Calcium: an active US FDA Type II Drug Master File or a CEP. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Switzerland (2) and China (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Levoleucovorin Calcium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/levoleucovorin-calcium
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Levoleucovorin Calcium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CERBIOS PHARMA SASwitzerlandCEP Company GMP cert on recordActive DMF 23437 · latest filing Jan 2010
- CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTDChinaCEPActive DMF 41242 · latest filing Jan 2025
- GMT FINE CHEMICALS SASwitzerlandCEP Company GMP cert on recordActive DMF 25198 · latest filing Aug 2011
- MERCK AND CIE KMGCEP Company GMP cert on recordActive DMF 20327 · latest filing Feb 2007
- SEACROSS PHARMA USA INCChinaActive DMF 38433 · latest filing May 2023
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Levoleucovorin Calcium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO., LTD. Chongqing | CN | CEP 2024-509 - Rev 00 Calcium levofolinate hydrate | Sept 2026 | — |
| MERCK & CIE KMG Schaffhausen | CH | CEP 2001-266 - Rev 07 Calcium levofolinate hydrate | Aug 2026 | Inspected Mar 2025 Switzerland |
| GMT FINE CHEMICALS S.A. Couvet | CH | CEP 2008-320 - Rev 08 Calcium levofolinate hydrate | Apr 2026 | Inspected Feb 2024 Switzerland |
| CERBIOS-PHARMA SA Barbengo | CH | CEP 2004-183 - Rev 04 Calcium levofolinate hydrate | Feb 2024 | Inspected Apr 2026 Switzerland |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Levoleucovorin Calcium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1908361).
Chemical identity
- IUPAC name
- calcium (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate
- Canonical SMILES
- C1[C@@H](N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].[Ca+2]
- InChIKey
- KVUAALJSMIVURS-QNTKWALQSA-L
- Synonyms
- Calcium (6s)-folinate, Calcium levofolinate, Calcium levofolinate (6s,l), Calcium levofolinate hydrate, Calcium levofolinate pentahydrate, CL 307,782, CL-307782, Elvorine, Folinic acid l-form calcium salt, Fusilev, Isovorin, Levofolinate calcium
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Folate Analog
- Chemical structure
- Folic Acid
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Levoleucovorin Calcium?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Levoleucovorin Calcium: CERBIOS PHARMA SA (Switzerland), CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD (China), GMT FINE CHEMICALS SA (Switzerland), MERCK AND CIE KMG and SEACROSS PHARMA USA INC (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Levoleucovorin Calcium Drug Master Files are active?
CERBIOS PHARMA SA (DMF 23437), CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD (DMF 41242), GMT FINE CHEMICALS SA (DMF 25198), MERCK AND CIE KMG (DMF 20327) and SEACROSS PHARMA USA INC (DMF 38433). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Levoleucovorin Calcium have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Levoleucovorin Calcium on the EDQM register, including CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO., LTD. Chongqing (CN), MERCK & CIE KMG Schaffhausen (CH), GMT FINE CHEMICALS S.A. Couvet (CH) and CERBIOS-PHARMA SA Barbengo (CH). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Levoleucovorin Calcium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Levoleucovorin Calcium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.